Finance

Lists
ARTV:NASDAQ
Artiva Biotherapeutics Inc
$4.19
0.00%
(0.00) 1D
$4.18
-0.24% (-0.010)
After hours
Closed: Nov 2, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
$4.21
High
$4.24
Low
$4.14
Mkt. cap
204.85M
Avg. vol.
912.45K
Volume
0.00
52-wk high
$14.53
52-wk low
$2.96
EPS
-$3.31
Shares outstanding
48.89M
No. of employees
115
Open
$4.21
High
$4.24
Low
$4.14
Mkt. cap
204.85M
Avg. vol.
912.45K
Volume
0.00
52-wk high
$14.53
52-wk low
$2.96
EPS
-$3.31
Shares outstanding
48.89M
No. of employees
115
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees115
Founded2019
Headquarters-
SectorBiotechnology
Websiteartivabio.com
Analyst ratings
Based on 5 analysts giving stock ratings to ARTV in the past 3 months
Hold
Buy
1
Hold
4
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current $4.19
$35.00 (+735.32%)
Average
$11.00 (+162.53%)
Lowest
$1.00 (-76.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Roger Song
Jefferies
Hold
Downgraded
$4.00
-4.5%
10/28/2026
Gil Blum
Needham
Hold
Downgraded
$1.00
-76.1%
10/27/2026
David Nierengarten
Wedbush
Hold
Downgraded
$4.00
-4.5%
10/27/2026
Tyler Van Buren
TD Cowen
Hold
Downgraded
-
-
10/27/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$35.00
+735.3%
10/01/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$40.00
+854.7%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
$23.00
+448.9%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
$40.00
+854.7%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.63M
16.99M
19.31M
21.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.26M
4.94M
5.12M
4.96M
Operating expense
22.90M
21.93M
24.43M
26.89M
Total operating expenses
22.90M
21.93M
24.43M
26.89M
Operating income
-22.90M
-21.93M
-24.43M
-26.89M
Other non operating income
-3.00K
-1.88M
2.00K
-1.00K
EBT including unusual items
-21.53M
-20.77M
-23.52M
-25.00M
EBT excluding unusual items
-21.53M
-22.65M
-23.52M
-25.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.53M
-20.77M
-23.52M
-25.00M
Net profit margin
-
-
-
-
Earnings per share
-0.88
-0.84
-0.95
-0.63
Interest and investment income
1.37M
1.16M
912.00K
1.89M
Interest expense
-
-
-
-
Net interest expenses
1.37M
1.16M
912.00K
1.89M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.24M
-21.27M
-23.76M
-26.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps